XBIO vs. XBIT

In the year-to-date period, XBIO achieves a -23.66% return, which is significantly higher than XBIT's -28.10% return. Over the past 10 years, XBIO has underperformed XBIT with an annualized return of -42.93%, while XBIT has yielded a comparatively higher -16.59% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XBIO Sharpe Ratio is -0.30, which is higher than the XBIT Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of XBIO and XBIT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither XBIO nor XBIT has paid dividends to shareholders.

The maximum XBIO drawdown since its inception was -99.94%, which is greater than XBIT's maximum drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for XBIO and XBIT.

Xenetic Biosciences, Inc. (XBIO) and XBiotech Inc. (XBIT) have volatilities of 12.87% and 12.84%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Xenetic Biosciences, Inc. and XBiotech Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.